Antibody microarray analysis of directly labelled complex proteomes

Area of Science:

• Biotechnology
• Proteomics
• Bioinformatics

Background:

• Antibody microarray technology has advanced significantly, moving from concept to high-performance platforms for complex proteome analysis.
• Key challenges in antibody microarray development involve sample and data handling.
• Direct labeling protocols and bioinformatic standards are emerging.

Purpose of the Study:

• To highlight advancements in antibody microarray technology, particularly in sample and data handling.
• To discuss the development of robust protocols for direct proteome labeling and analysis.
• To introduce emerging bioinformatic standards for antibody microarray data.

Main Methods:

• Development of robust protocols for direct labeling of whole proteomes.
• Utilization of sensitive fluorescent-based sensing.
• Adaptation of methods from DNA microarray analysis for bioinformatic standards.

Main Results:

• Established high-performing antibody microarray platforms capable of targeting non-fractionated complex proteomes.
• Designed robust protocols for direct labeling of whole proteomes.
• Developed initial bioinformatic standards for antibody microarray data analysis, with biotin tagging as a preferred approach.

Conclusions:

• Antibody microarray technology is a powerful tool for proteome analysis.
• Direct labeling and improved data handling are crucial for advancing the technology.
• Further standardization of operating procedures is necessary for widespread adoption.